Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes

Heart failure remains a significant cause of morbidity and mortality following myocardial infarction. Cardiac remuscularization with transplantation of human pluripotent stem cell-derived cardiomyocytes is a promising preclinical therapy to restore function. Recent large animal data, however, have r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kenta, Neidig, Lauren E., Yang, Xiulan, Weber, Gerhard J., El-Nachef, Danny, Tsuchida, Hiroshi, Dupras, Sarah, Kalucki, Faith A., Jayabalu, Anu, Futakuchi-Tsuchida, Akiko, Nakamura, Daisy S., Marchianò, Silvia, Bertero, Alessandro, Robinson, Melissa R., Cain, Kevin, Whittington, Dale, Tian, Rong, Reinecke, Hans, Pabon, Lil, Knollmann, Björn C., Kattman, Steven, Thies, R. Scott, MacLellan, W. Robb, Murry, Charles E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514851/
https://www.ncbi.nlm.nih.gov/pubmed/34506727
http://dx.doi.org/10.1016/j.stemcr.2021.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514851/
https://www.ncbi.nlm.nih.gov/pubmed/34506727
http://dx.doi.org/10.1016/j.stemcr.2021.08.005

Ejemplares similares